BIOLOGICAL PRODUCTION OF SEMISYNTHETIC OPIATES USING GENETICALLY-ENGINEERED BACTERIA

C E FRENCH, A M HAILES, D A RATHBONE, M T LONG, D L WILLEY, N C BRUCE, Chris French

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Semisynthetic derivatives of morphine and related alkaloids re in widespread clinical use. Due to the complexity of these molecules, however, chemical transformations are difficult to achieve in high yields. We recently identified the powerful analgesic hydromorphone as an intermediate in the metabolism of morphine by Pseudomonas putida M10. Here we describe the construction of recombinant strains of Escherichia coli that express morphine dehydrogenase and morphinone reductase. These strains are capable of efficiently transforming the naturally occurring alkaloids morphine and codeine to hydro-morphone and antitussive hydrocodone, respectively. Our results demonstrate the potential for recombinant DNA technology to provide biological routes for the synthesis of known and novel semi-synthetic opiate drugs.

Original languageEnglish
Pages (from-to)674-676
Number of pages3
JournalBio-technology
Volume13
Issue number7
Publication statusPublished - Jul 1995

Fingerprint

Dive into the research topics of 'BIOLOGICAL PRODUCTION OF SEMISYNTHETIC OPIATES USING GENETICALLY-ENGINEERED BACTERIA'. Together they form a unique fingerprint.

Cite this